Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.semtcvs.2021.01.037 | DOI Listing |
Publication Analysis
Top Keywords
commentary rasi
4
rasi toxicity
4
toxicity conducting
4
conducting aki
4
aki patients
4
patients undergoing
4
undergoing cardiac
4
cardiac surgery
4
surgery questioned?
4
commentary
1
Similar Publications
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
December 2022
Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
Commentary: Should RASi Toxicity Conducting AKI on Patients Undergoing Cardiac Surgery be Questioned?
Semin Thorac Cardiovasc Surg
March 2022
Cardiology Department, Hospital La Luz, Madrid, Spain.
Increasing the impact of Post Authorisation Safety Studies: transparency is key.
Eur J Intern Med
January 2021
EMA, Amsterdam, The Netherlands, and University Tor Vergata, Rome, Italy.
Clinical trial publications: A sufficient basis for healthcare decisions?
Eur J Intern Med
January 2020
European Medicines Agency (EMA), Amsterdam, the Netherlands; University Tor Vergata, Rome, Italy. Electronic address:
Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.
Clin Pharmacol Ther
January 2020
European Medicines Agency, Amsterdam, The Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!